Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun;51(6):1013-1018.
doi: 10.1007/s11255-019-02154-w. Epub 2019 Apr 24.

Asymptomatic hyperuricemia and cardiovascular mortality in patients with chronic kidney disease who progress to hemodialysis

Tadej Petreski  1 , Robert Ekart  2   3 , Radovan Hojs  4   3 , Sebastjan Bevc  4   3
Affiliations

Asymptomatic hyperuricemia and cardiovascular mortality in patients with chronic kidney disease who progress to hemodialysis

Tadej Petreski et al. Int Urol Nephrol. 2019 Jun.

Abstract

Purpose: Hyperuricemia has been associated with higher mortality in the general population, but less is known about CKD patients. The aim of our study was to determine the impact of elevated serum uric acid on cardiovascular mortality of CKD patients who later progress to hemodialysis.

Methods: In this retrospective study, 120 CKD patients (entire population of patients with ESKD on January 1st, 2012) were observed from their first visit at the Nephrology outpatient clinic, while transitioning to hemodialysis, and until their death or January 1, 2016. After non-cardiovascular death exclusion, 83 CKD patients (33 female, 50 male) were left for further analysis. The average time of observation was 8.8 ± 4.2 years. Serum uric acid was measured regularly (every 3 months). No patients were treated for hyperuricemia. Mean uric acid of 420 µmol/L was set as a cut-off between normouricemic and hyperuricemic patients as per the laboratory's reference values. Survival rates were analyzed using Kaplan-Meier survival curves. Three Cox regression models were used to assess the influence of uric acid on survival.

Results: Mean uric acid was 379.8 ± 71.6 µmol/L (range 220-574). Sixty-three (75.9%) patients were normouricemic and 20 (24.1%) were hyperuricemic. Cholesterol was the only variable to show statistically significant difference (p = 0.004) between the groups. Bivariate analysis revealed an association between death and age, hyperuricemia, arterial hypertension, and history of cardiovascular disease. Kaplan-Meier survival analysis showed higher risk of cardiovascular death for hyperuricemic patients (log rank test; p < 0.0005). In Cox regression models, hyperuricemia remained a predictor of cardiovascular mortality (SE = 0.500, Exp(B) = 14.120, 95% CI 5.297-37.640) in our patients next to age and arterial hypertension.

Conclusion: The results indicate an association between hyperuricemia and cardiovascular mortality in CKD patients who transition to hemodialysis.

Keywords: Cardiovascular disease complications; Chronic renal insufficiency; Hyperuricemia; Renal dialysis; Risk factors.

PubMed Disclaimer

References

    1. Am J Physiol Renal Physiol. 2008 Oct;295(4):F1134-41 - PubMed
    1. Kidney Int. 2011 Apr;79(7):765-72 - PubMed
    1. Clin J Am Soc Nephrol. 2011 Oct;6(10):2470-7 - PubMed
    1. Nucleosides Nucleotides Nucleic Acids. 2011 Dec;30(12):1039-44 - PubMed
    1. Adv Chronic Kidney Dis. 2012 Nov;19(6):386-91 - PubMed

LinkOut - more resources